Dec 07, 2016 13:00 pm UTC| Business
NEWARK, Calif., Dec. 07, 2016 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies to treat indications with high unmet medical need, today announced the...
Vera Bradley Announces Fiscal Third Quarter 2017 Results
Dec 07, 2016 13:00 pm UTC| Business
Third quarter net revenues totaled $126.7 million, flat with last year Third quarter net income totaled $8.8 million, or $0.24 per diluted share (including a $0.04 per share income tax benefit related to the release of...
Dec 07, 2016 13:00 pm UTC| Business
INDIANAPOLIS, Dec. 07, 2016 -- The Finish Line, Inc. (NASDAQ:FINL) today announced the following webcast: What:Third Quarter Fiscal 2017 Financial Results Conference CallWhen:Wednesday, December 21, 2016 at 8:30 a.m....
Dec 07, 2016 13:00 pm UTC| Business
AUSTIN, Texas, Dec. 07, 2016 -- XBiotech Inc. (NASDAQ:XBIT), developer of True Human™ therapeutic antibodies, today announced that enrollment has been completed in its randomized, double-blind, placebo-controlled Phase...
Dec 07, 2016 13:00 pm UTC| Business
AUSTIN, Texas, Dec. 07, 2016 -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat genetic rare diseases...
Dec 07, 2016 12:54 pm UTC| Business
RUTHERFORD, N.J., Dec. 07, 2016 -- Cancer Genetics, Inc. (Nasdaq:CGIX)(“CGI” or “The Company”), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, announced a collaboration...
Dec 07, 2016 12:30 pm UTC| Business
OKLAHOMA CITY, Dec. 07, 2016 -- Gulfport Energy Corporation (Nasdaq:GPOR) (“Gulfport” or the “Company”) today announced that the Company has entered into a definitive agreement with a third-party to acquire...